Ingersoll Rand Acquires Fox s.r.l., Expanding Metering and Dosing Capabilities

Manufactures hydropneumatic accumulators, pulsation dampeners, calibration pots, and instrumentation to stabilize flow and pressure in dosing systems, protecting downstream equipment and improving the performance in complex solutions. The acquisition will enable Ingersoll Rand to combine technologies with Fox’s offerings to provide comprehensive, end-to-end metering and dosing solutions. 

Ingersoll Rand Inc., the global provider of mission-critical flow creation and life science and industrial solutions, this help company expand the metering and dosing technologies portfolio. The technologies help protect downstream equipment while improving performance, durability, and reliability in complex pumping applications. 

According to Towards Healthcare, the pharmaceutical pump market is projected to experience significant growth, with estimates suggesting the market size will increase from USD 13.85 billion in 2026 to approximately USD 27.46 billion by 2035, representing a compound annual growth rate (CAGR) of 7.9% from 2026 to 2035. Growth is driven by the increasing demand as pharmaceutical companies seek to eliminate costly and time-consuming cleaning processes, prevent cross-contamination, and ensure product integrity. Rising demand for targeted, controlled, and patient-friendly drug delivery, such as ambulatory infusion pumps and nasal spray pumps, is accelerating market growth. 

About Ingersoll Rand Inc. 

The company is driven by an entrepreneurial spirit and ownership mindset, which is dedicated to Making Life Better for employees, customers, shareholders, and the planet. Customers lean on us for exceptional performance and durability in mission-critical flow creation and life science and industrial solutions. 

The main focus is on air and gas compressors, vacuum pumps, fluid handling systems, and precision liquid handling devices. Manufactures rotary screw, reciprocating, and centrifugal air compressors, alongside air treatment equipment, power tools, and material lifting systems. Customers look for exceptional performance and durability in mission-critical flow creation and industrial solutions. 

Chairman and chief executive officer of Ingersoll Rand, Vicente Reynal, stated that the addition of Fox strengthens our metering and dosing portfolio and enhances our ability to deliver more complete, competitive solutions for customers. 

A recent report by Towards Healthcare highlights that the pharmaceutical pump market is witnessing growth due to the rising complexity of biologics, gene therapies, and precision medicine requires extremely tight, sterile manufacturing processes that traditional pumps cannot fulfill. Despite the growth potential, the market faces challenges such as supply chain bottlenecks and the need for continuous innovation to meet the evolving demands of healthcare providers and patients. The market also sees a shift towards electronic and wearable pumps, aligning with the trends of personalized medicine and home healthcare.